Skip to main content
NIH funding notice RFA-AG-24-040

Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)

Closed on February 15, 2024.

Posted
October 19, 2023
Close date
February 15, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,043,730 in first-year total cost, median $3,521,865.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 ZIJ-A (O3)]2

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
  2. INDIANA UNIVERSITY INDIANAPOLIS1
Competing awards under RFA-AG-24-040 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Development of Human Microphysiological Systems for Testing of AD/ADRD Interventional Strategies across Genetically Diverse Populations1U54AG090669-01BENNETT, DAVID ALANCARTER, GREGORY WLEAL, KARINALONGO, FRANK MPAULL, DANIEL JOHNYOUNG-PEARSE, TRACY LBRIGHAM AND WOMEN'S HOSPITAL, MA$3,708,714ZAG1
2025Microphysiological systems to Advance Precision medicine for Alzheimer's Disease and Related Dementias (MAP-AD)1U54AG090792-01CANFIELD, SCOTT GDAGE, JEFFREYGUO, FENGHUANG, KUNLAMB, BRUCE TMEYER, JASON STEPHENRICHARDSON, TIMOTHY IWILCOCK, DONNA MINDIANA UNIVERSITY INDIANAPOLIS, IN$3,335,016ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AG-24-040: Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed) | ScienceDex | ConductScience